Search / Trial NCT06234826

Skeletal Muscle Wasting in ICU Patients

Launched by FRANK VANDENABEELE · Jan 30, 2024

Trial Information

Current as of October 08, 2024

Recruiting

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * age \>18y
  • * admitted to ICU
  • * enteral nutrition line in situ
  • * arterial line (any location) in situ
  • * expected stay ICU \>7d
  • Exclusion Criteria:
  • * spinal cord injury
  • * chronic use of corticosteroids before hospital admission
  • * Contraindication to enteral infusion (e.g. due to GI-tract perforation)
  • * Kidney or liver failure
  • * therapeutic anti coagulation

About Frank Vandenabeele

Frank Vandenabeele is a distinguished clinical trial sponsor specializing in innovative research and development in the healthcare sector. With a commitment to advancing medical science, the organization focuses on designing and executing clinical trials that adhere to the highest ethical and regulatory standards. Leveraging a robust network of industry partnerships and a team of experienced professionals, Frank Vandenabeele aims to facilitate the discovery and delivery of novel therapies that improve patient outcomes. Their dedication to transparency and collaboration underscores a mission to contribute significantly to the advancement of medical knowledge and treatment options.

Locations

Hasselt, Limburg, Belgium

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0